Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CRONNASDAQ:TLRY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCRONCronos Group$2.03-1.0%$1.85$1.60▼$2.69$790.08M1.061.30 million shs1.29 million shsTLRYTilray$0.44-1.0%$0.52$0.41▼$2.15$445.27M1.9528.29 million shs14.62 million shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCRONCronos Group0.00%-5.14%+9.73%+3.05%-27.24%TLRYTilray0.00%-10.63%-10.14%-53.50%-76.22%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCRONCronos Group0.9625 of 5 stars0.03.00.00.03.30.01.3TLRYTilray1.3676 of 5 stars3.11.00.00.01.90.01.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCRONCronos Group 0.00N/AN/AN/ATLRYTilray 2.25Hold$1.92333.24% UpsideCurrent Analyst Ratings BreakdownLatest CRON and TLRY Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/14/2025TLRYTilrayRoth CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral4/9/2025TLRYTilrayPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$2.00 ➝ $1.00(Data available from 5/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCRONCronos Group$124.59M6.28N/AN/A$2.87 per share0.71TLRYTilray$210.48M2.12N/AN/A$4.14 per share0.11Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCRONCronos Group-$73.96M$0.13N/A67.671.74-42.65%-2.56%-2.47%N/ATLRYTilray-$244.98M-$1.05N/AN/AN/A-30.95%-4.40%-3.57%8/4/2025 (Estimated)Latest CRON and TLRY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025CRONCronos Group$0.01$0.02+$0.01$0.02$45.44 million$33.62 million4/8/2025Q3 2025TLRYTilray-$0.04-$0.10-$0.06-$0.87$213.38 million$185.78 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCRONCronos GroupN/AN/AN/AN/AN/ATLRYTilrayN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCRONCronos GroupN/A24.2423.05TLRYTilray0.102.541.58Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCRONCronos Group8.71%TLRYTilray9.35%Insider OwnershipCompanyInsider OwnershipCRONCronos Group7.30%TLRYTilray0.87%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCRONCronos Group450385.41 million356.14 millionOptionableTLRYTilray2,6501.01 billion929.50 millionOptionableCRON and TLRY HeadlinesRecent News About These CompaniesTilray (NASDAQ:TLRY) Stock Price Down 2.2% - What's Next?May 24 at 4:02 PM | marketbeat.comTilray (NASDAQ:TLRY) Trading 1.6% Higher - Should You Buy?May 23 at 2:12 PM | marketbeat.comTilray (NASDAQ:TLRY) Trading Down 0.2% - Should You Sell?May 22 at 2:20 PM | marketbeat.comIntroducing Y'all's Beer: A True Taste of Texas from Revolver BrewingMay 22 at 8:00 AM | globenewswire.comTilray Medical Brings Canada's Iconic Cannabis Brand Good Supply to GermanyMay 22 at 7:00 AM | globenewswire.comTilray (NASDAQ:TLRY) Stock Price Up 1.5% - Still a Buy?May 21, 2025 | marketbeat.comTop Marijuana Stocks In A Volatile MarketMay 21, 2025 | marijuanastocks.comTilray (NASDAQ:TLRY) Shares Down 6.9% - Should You Sell?May 20, 2025 | marketbeat.comTidal Investments LLC Has $14.09 Million Position in Tilray Inc (NASDAQ:TLRY)May 20, 2025 | marketbeat.comTilray Brands (NasdaqGS:TLRY) Plans Reverse Stock SplitMay 17, 2025 | finance.yahoo.comTilray (NASDAQ:TLRY) Trading Up 4.5% - Time to Buy?May 17, 2025 | marketbeat.comTilray (NASDAQ:TLRY) Shares Down 4.4% - Time to Sell?May 16, 2025 | marketbeat.comTilray (NASDAQ:TLRY) Stock Price Down 1.4% - Here's What HappenedMay 15, 2025 | marketbeat.comTilray (NASDAQ:TLRY) Stock Price Down 2.1% - Should You Sell?May 14, 2025 | marketbeat.comTilray Brands Announces the Launch of XMG Atomic Sours: New THC Beverages and EdiblesMay 14, 2025 | globenewswire.comTilray Inc (NASDAQ:TLRY) Shares Purchased by Dimensional Fund Advisors LPMay 14, 2025 | marketbeat.comTilray (NASDAQ:TLRY) Stock Price Up 1.2% - Here's WhyMay 13, 2025 | marketbeat.comBest Canadian Marijuana Stocks for U.S. Market ExposureMay 13, 2025 | marijuanastocks.com2 Stocks Near Their 52-Week Lows That Still Aren't Worth BuyingMay 13, 2025 | fool.comTilray (NASDAQ:TLRY) Shares Down 2.1% - Here's WhyMay 10, 2025 | marketbeat.comTilray (NASDAQ:TLRY) Trading Up 1.5% - Time to Buy?May 9, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCRON and TLRY Company DescriptionsCronos Group NASDAQ:CRON$2.03 -0.02 (-0.98%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$2.03 0.00 (0.00%) As of 05/23/2025 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.Tilray NASDAQ:TLRY$0.44 0.00 (-1.03%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$0.44 0.00 (-0.09%) As of 05/23/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/19 - 05/23 Trade Desk Silences Critics; Recovery Looks Poised to Continue Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH Stock Turbulence for Joby Shares: What's Behind the Recent Dip? Pfizer's 7.5% Dividend: Income Haven or House of Cards? TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain These ETFs Provide Easy Exposure to Growing International Markets Advance Auto Parts Jumps on Surprise Earnings Beat Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
